We help protect as many people as possible from life-threatening illness with quality vaccines that make an impact across all stages of life by combining unrelenting passion, global impact, and an enduring quest for progress to unlock the promise and value that vaccines hold for our world.

Our vaccine R&D program includes an ongoing focus on the prevention of pneumococcal disease, including in adults. We are also advancing vaccines for additional deadly adolescent and adult infections including Meningococcal disease, Staphylococcus aureus and Clostridium difficile. 

Click here to find out more about our global Vaccines portfolio